361 related articles for article (PubMed ID: 10208755)
1. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Ishiguro I
Pharmacol Res; 1999 Apr; 39(4):261-7. PubMed ID: 10208755
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of compound 48/80-induced gastric lesions in rats.
Takeuchi K; Ohtsuki H; Okabe S
Dig Dis Sci; 1986 Apr; 31(4):392-400. PubMed ID: 3956335
[TBL] [Abstract][Full Text] [Related]
3. Repeated recurrence of gastric mucosal lesions in rats after a single treatment with compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():139-48. PubMed ID: 20388957
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of irritative activity of compound 48/80 on rat gastric mucosa.
Takeuchi K; Ohtsuki H; Nobuhara Y; Okabe S
Digestion; 1986; 33(1):34-44. PubMed ID: 3940236
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of teprenone against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
J Pharmacol Sci; 2003 Nov; 93(3):337-46. PubMed ID: 14646252
[TBL] [Abstract][Full Text] [Related]
6. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
[TBL] [Abstract][Full Text] [Related]
7. Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kamiya Y; Imai Y; Arisawa T; Nakano H
Pharmacology; 2005 Jul; 74(4):182-92. PubMed ID: 15855831
[TBL] [Abstract][Full Text] [Related]
8. Differential effects on sympathetic neurotransmission of mast cell degranulation by compound 48/80 or antigen in the rat isolated perfused heart.
Ries P; Fuder H
Methods Find Exp Clin Pharmacol; 1994; 16(6):419-35. PubMed ID: 7530791
[TBL] [Abstract][Full Text] [Related]
9. Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions is gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Nishida K; Ishiguro I
Dig Dis Sci; 1997 Jun; 42(6):1221-32. PubMed ID: 9201088
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
Jpn J Pharmacol; 2002 Dec; 90(4):295-303. PubMed ID: 12501005
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of ebselen on acute gastric mucosal lesion development in rats treated with compound 48/80.
Kobayashi T; Ohta Y; Yoshino J
Eur J Pharmacol; 2001 Mar; 414(2-3):271-9. PubMed ID: 11239928
[TBL] [Abstract][Full Text] [Related]
12. Participation of xanthine-xanthine oxidase system and neutrophils in development of acute gastric mucosal lesions in rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Ishiguro I
Dig Dis Sci; 1999 Sep; 44(9):1865-74. PubMed ID: 10505727
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Kobayashi T; Ohta Y; Inui K; Yoshino J; Nakazawa S
Pharmacol Res; 2002 Jul; 46(1):75-84. PubMed ID: 12208124
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral vitamin E administration on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2006 Apr; 29(4):675-83. PubMed ID: 16595898
[TBL] [Abstract][Full Text] [Related]
15. Effect of H1 and H2 receptor blockers on mobilization of myocardial carnosine to histamine during compound 48/80-induced shock in young rats.
Fitzpatrick JC; Fisher H; Flancbaum L
Circ Shock; 1990 Feb; 30(2):145-53. PubMed ID: 1968787
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism for the gastric mucosal protection by famotidine in rats.
Miyata K; Kamato T; Nishida A; Honda K
Jpn J Pharmacol; 1991 Feb; 55(2):211-22. PubMed ID: 2067140
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats.
Tabuchi Y; Kawarabayashi K; Furuhama K
Agents Actions; 1994 Mar; 41(1-2):21-4. PubMed ID: 7521568
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of Shigyaku-san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kobayashi T; Hayashi T; Inui K; Yoshino J; Nakazawa S
Phytother Res; 2006 Apr; 20(4):256-62. PubMed ID: 16557606
[TBL] [Abstract][Full Text] [Related]
19. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of teprenone on acute gastric mucosal lesion progression in compound 48/80-treated rats.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Kitagawa A; Nakazawa S
Eur J Pharmacol; 2004 Mar; 487(1-3):223-32. PubMed ID: 15033395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
